{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:06:35Z","timestamp":1778033195904,"version":"3.51.4"},"reference-count":25,"publisher":"American Society of Hematology","issue":"12","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Transient abnormal myelopoiesis (TAM) occurs in 10% of neonates with Down syndrome (DS). Although most patients show spontaneous resolution of TAM, early death occurs in \u223c20% of cases. Therefore, new biomarkers are needed to predict early death and determine therapeutic interventions. This study aimed to determine the association between clinical characteristics and cytokine levels in patients with TAM. A total of 128 patients with DS with TAM enrolled in the TAM-10 study conducted by the Japanese Pediatric Leukemia\/Lymphoma Study Group were included in this study. Five cytokine levels (interleukin-1b [IL-1b], IL-1 receptor agonist, IL-6, IL-8, and IL-13) were significantly higher in patients with early death than in those with nonearly death. Cumulative incidence rates (CIRs) of early death were significantly associated with high levels of the 5 cytokines. Based on unsupervised consensus clustering, patients were classified into 3 cytokine groups: hot-1 (n\u00a0= 37), hot-2 (n\u00a0= 42), and cold (n\u00a0= 49). The CIR of early death was significantly different between the cytokine groups (hot-1\/2, n\u00a0= 79; cold, n\u00a0= 49; hot-1\/2 CIR, 16.5% [95% confidence interval (CI), 7.9-24.2]; cold CIR, 2.0% [95%\u00a0CI, 0.0-5.9]; P\u00a0= .013). Furthermore, cytokine groups (hot-1\/2 vs cold) were independent poor prognostic factors in the multivariable analysis for early death (hazard ratio, 15.53; 95%\u00a0CI, 1.434-168.3; P\u00a0= .024). These results provide valuable information that cytokine level measurement was useful in predicting early death in patients with TAM and might help to determine the need for therapeutic interventions. This trial was registered at UMIN Clinical Trials Registry as #UMIN000005418.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011628","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:01:31Z","timestamp":1714586491000},"page":"3120-3129","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-0753","authenticated-orcid":false,"given":"Genki","family":"Yamato","sequence":"first","affiliation":[{"name":"1Department of Hematology\/Oncology, Gunma Children's Medical Center, Shibukawa, Japan"},{"name":"2Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-9655","authenticated-orcid":false,"given":"Yusuke","family":"Tsumura","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-3779","authenticated-orcid":false,"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-7241","authenticated-orcid":false,"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"5Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsukagoshi","sequence":"additional","affiliation":[{"name":"6Department of Research Group, Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeko","family":"Kaburagi","sequence":"additional","affiliation":[{"name":"1Department of Hematology\/Oncology, Gunma Children's Medical Center, Shibukawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Shiba","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3089-2332","authenticated-orcid":false,"given":"Yoshiyuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"8Department of Allergy and Immunology, Gunma Children's Medical Center, Shibukawa, Japan"},{"name":"9Department of Pediatrics, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[{"name":"10Children\u2019s Cancer Center, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-0334","authenticated-orcid":false,"given":"Tomoko","family":"Kawai","sequence":"additional","affiliation":[{"name":"11Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[{"name":"12Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0168-2475","authenticated-orcid":false,"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[{"name":"12Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"13Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Hayashi","sequence":"additional","affiliation":[{"name":"1Department of Hematology\/Oncology, Gunma Children's Medical Center, Shibukawa, Japan"},{"name":"14Institute of Physiology and Medicine, Jobu University, Takasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"6","key":"2024062415062121200_bib1","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","article-title":"Incidence and clinical implications of GATA1 mutations in newborns with down syndrome","volume":"110","author":"Pine","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2024062415062121200_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/s41375-021-01171-y","article-title":"Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome","volume":"35","author":"Yamato","year":"2021","journal-title":"Leukemia"},{"issue":"26","key":"2024062415062121200_bib3","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","article-title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children\u2019s Oncology Group Study A2971","volume":"118","author":"Gamis","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2024062415062121200_bib4","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","article-title":"Treatment and prognostic impact of transient leukemia in neonates with Down syndrome","volume":"111","author":"Klusmann","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2024062415062121200_bib5","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"Children\u2019s Oncology Group (COG). a prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children\u2019s Oncology Group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2024062415062121200_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2008.07231.x","article-title":"Risk factors for early death in neonates with Down syndrome and transient leukaemia","volume":"142","author":"Muramatsu","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"2024062415062121200_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjh.15390","article-title":"Guidelines for the investigation and management of transient leukaemia of Down syndrome","volume":"182","author":"Tunstall","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"2024062415062121200_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pedneo.2018.09.005","article-title":"Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis","volume":"60","author":"Kinjo","year":"2019","journal-title":"Pediatr Neonatol"},{"issue":"1 Pt 2","key":"2024062415062121200_bib9","first-page":"e87","article-title":"Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing","volume":"22","author":"Kato","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2024062415062121200_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest -- non--parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"2024062415062121200_bib11","first-page":"1","article-title":"missMDA: a package for handling missing values in multivariate data analysis","volume":"70","author":"Josse","year":"2016","journal-title":"J\u00a0Stat Softw"},{"issue":"3","key":"2024062415062121200_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2024062415062121200_bib13","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"issue":"11","key":"2024062415062121200_bib14","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2024062415062121200_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family","volume":"22","author":"Boraschi","year":"2011","journal-title":"Eur Cytokine Netw"},{"issue":"4","key":"2024062415062121200_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"Palmer. Il-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2024062415062121200_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4049\/jimmunol.127.2.412","article-title":"T\u00a0cell-replacing factor-(TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF","volume":"127","author":"Muraguchi","year":"1981","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"2024062415062121200_bib18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.167.3.1253","article-title":"B\u00a0cell stimulating factor 2\/interleukin 6 is a costimulant for human thymocytes and T lymphocytes","volume":"167","author":"Lotz","year":"1988","journal-title":"J\u00a0Exp Med"},{"issue":"7","key":"2024062415062121200_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in bone metastasis and cancer progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur J Cancer"},{"issue":"30","key":"2024062415062121200_bib20","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1038\/onc.2009.130","article-title":"Interleukin 6 secreted fromadipose stromal cells promotes migration and invasion of breast cancer cells","volume":"28","author":"Walter","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"2024062415062121200_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1541-7786.MCR-09-0496","article-title":"Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6","volume":"8","author":"Foran","year":"2010","journal-title":"Mol Cancer Res"},{"issue":"3","key":"2024062415062121200_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000346196","article-title":"Tumor-associated macrophage promotes tumor progression via STAT3 signaling inhepatocellular carcinoma","volume":"80","author":"Mano","year":"2013","journal-title":"Pathobiology"},{"issue":"2","key":"2024062415062121200_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1620\/tjem.241.149","article-title":"Cytokine profiles in pericardial effusion in a Down syndrome infant with transient abnormal myelopoiesis","volume":"241","author":"Shitara","year":"2017","journal-title":"Tohoku J Exp Med"},{"issue":"13","key":"2024062415062121200_bib24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/bloodadvances.2018018945","article-title":"Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD prevention 2007 study","volume":"2","author":"Flasinski","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"2024062415062121200_bib25","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1182\/blood-2010-05-282426","article-title":"Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia","volume":"116","author":"Kanezaki","year":"2010","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3120\/2232052\/blooda_adv-2023-011628-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3120\/2232052\/blooda_adv-2023-011628-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:10:16Z","timestamp":1719241816000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/12\/3120\/515974\/Cytokine-profiling-in-128-patients-with-transient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011628","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}